AI
VENTE TOTALE: 609 704 titres (~6 278 892,14 $ US)
- Insiders
- SIEBEL THOMAS M
- Total bought
- —
- Total sold
- $6,278,892
- Last activity
- 2026-09-02
- Last synced
-
2026-09-08 09:54:45
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-07
C3.ai (AI) presents a deeply unfavorable risk/reward profile: operating and net margins of -188% combined with persistent negative free cash flow signal severe fundamental deterioration that the adequate current ratio…
The first sentence of the analysis written for AI on 2026-08-07 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 30.9% | 60.6% | 57.5% | 67.6% | 74.8% | |
| Ebit Margin | -187.6% | -74.0% | -89.8% | -100.5% | -75.7% | |
| Ebitda Margin | -182.2% | -70.7% | -85.7% | -98.2% | -73.6% | |
| Operating Profit Margin | -194.9% | -83.4% | -102.5% | -108.9% | -77.6% | |
| Pretax Profit Margin | -187.6% | -74.0% | -89.8% | -100.5% | -75.7% | |
| Continuous Operations Profit Margin | -187.9% | -74.2% | -90.1% | -100.8% | -76.0% | |
| Net Profit Margin | -187.9% | -74.2% | -90.1% | -100.8% | -76.0% | |
| Bottom Line Profit Margin | -187.9% | -74.2% | -90.1% | -100.8% | -76.0% | |
| Current Ratio | 6.643 | 6.856 | 8.838 | 6.534 | 7.062 | |
| Quick Ratio | 6.643 | 6.856 | 8.838 | 6.534 | 7.167 | |
| Solvency Ratio | -2.811 | -1.472 | -1.619 | -1.516 | -1.030 | |
| Cash Ratio | 0.621 | 1.246 | 1.633 | 2.094 | 2.261 | |
| Price To Earnings Ratio | -2.636 | -9.826 | -9.628 | -7.604 | -9.234 | |
| Price To Earnings Growth Ratio | -0.053 | 2.299 | 2.144 | -0.229 | -0.088 | |
| Forward Price To Earnings Growth Ratio | -0.053 | 2.299 | 2.144 | -0.229 | -0.088 | |
| Price To Earnings Diluted Ratio | -2.636 | -9.826 | -9.628 | -7.604 | -9.234 | |
| Price To Earnings Diluted Growth Ratio | -0.053 | 2.299 | 2.144 | -0.229 | -0.088 | |
| Price To Book Ratio | 1.898 | 3.389 | 3.079 | 2.201 | 1.793 | |
| Price To Sales Ratio | 4.958 | 7.303 | 8.659 | 7.671 | 7.018 | |
| Price To Free Cash Flow Ratio | -6.506 | -63.926 | -29.759 | -10.932 | -19.546 | |
| Price To Operating Cash Flow Ratio | -6.572 | -68.618 | -43.123 | -17.690 | -20.516 | |
| Debt To Assets Ratio | 0.007 | 0.005 | 0.003 | 0.002 | 0.003 | |
| Debt To Equity Ratio | 0.009 | 0.006 | 0.004 | 0.003 | 0.004 | |
| Debt To Capital Ratio | 0.008 | 0.006 | 0.004 | 0.003 | 0.004 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.249 | 1.224 | 1.189 | 1.186 | 1.183 | |
| Working Capital Turnover Ratio | 0.364 | 0.494 | 0.399 | 0.321 | 0.258 | |
| Operating Cash Flow Ratio | -1.771 | -0.314 | -0.609 | -0.850 | -0.576 | |
| Operating Cash Flow Sales Ratio | -0.754 | -0.106 | -0.201 | -0.434 | -0.342 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.010 | 1.073 | 1.449 | 1.618 | 1.050 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -33.851 | -8.635 | -19.331 | -49.462 | -23.931 | |
| Capital Expenditure Coverage Ratio | -98.944 | -13.625 | -2.227 | -1.618 | -20.150 | |
| Dividend Paid And Capex Coverage Ratio | -98.944 | -13.625 | -2.227 | -1.618 | -20.150 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -2.588 | -9.747 | -9.487 | -6.731 | -7.727 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 30.9% | ▼-29.7% | ▼-27.4% |
| Ebit Margin | -187.6% | ▼-113.7% | ▼-82.1% |
| Ebitda Margin | -182.2% | ▼-111.5% | ▼-80.1% |
| Operating Profit Margin | -194.9% | ▼-111.5% | ▼-81.4% |
| Pretax Profit Margin | -187.6% | ▼-113.7% | ▼-82.1% |
| Continuous Operations Profit Margin | -187.9% | ▼-113.7% | ▼-82.2% |
| Net Profit Margin | -187.9% | ▼-113.7% | ▼-82.2% |
| Bottom Line Profit Margin | -187.9% | ▼-113.7% | ▼-82.2% |
| Current Ratio | 6.643 | ▼-0.213 | ▼-0.543 |
| Quick Ratio | 6.643 | ▼-0.213 | ▼-0.565 |
| Solvency Ratio | -2.811 | ▼-1.339 | ▼-1.121 |
| Cash Ratio | 0.621 | ▼-0.625 | ▼-0.950 |
| Price To Earnings Ratio | -2.636 | ▲7.190 | ▲5.150 |
| Price To Earnings Growth Ratio | -0.053 | ▼-2.353 | ▼-0.868 |
| Forward Price To Earnings Growth Ratio | -0.053 | ▼-2.353 | ▼-0.868 |
| Price To Earnings Diluted Ratio | -2.636 | ▲7.190 | ▲5.150 |
| Price To Earnings Diluted Growth Ratio | -0.053 | ▼-2.353 | ▼-0.868 |
| Price To Book Ratio | 1.898 | ▼-1.491 | ▼-0.574 |
| Price To Sales Ratio | 4.958 | ▼-2.345 | ▼-2.164 |
| Price To Free Cash Flow Ratio | -6.506 | ▲57.419 | ▲19.627 |
| Price To Operating Cash Flow Ratio | -6.572 | ▲62.045 | ▲24.731 |
| Debt To Assets Ratio | 0.007 | ▲0.002 | ▲0.003 |
| Debt To Equity Ratio | 0.009 | ▲0.003 | ▲0.004 |
| Debt To Capital Ratio | 0.009 | ▲0.003 | ▲0.004 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 1.249 | ▲0.025 | ▲0.042 |
| Working Capital Turnover Ratio | 0.364 | ▼-0.130 | ▼-0.003 |
| Operating Cash Flow Ratio | -1.771 | ▼-1.458 | ▼-0.947 |
| Operating Cash Flow Sales Ratio | -0.754 | ▼-0.648 | ▼-0.387 |
| Free Cash Flow Operating Cash Flow Ratio | 1.010 | ▼-0.063 | ▼-0.230 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | -33.851 | ▼-25.215 | ▼-6.809 |
| Capital Expenditure Coverage Ratio | -98.944 | ▼-85.319 | ▼-71.631 |
| Dividend Paid And Capex Coverage Ratio | -98.944 | ▼-85.319 | ▼-71.631 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -2.588 | ▲7.159 | ▲4.668 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $1.24B | $2.84B | $2.69B | $2.05B | $1.77B | |
| Enterprise value | $1.18B | $2.68B | $2.53B | $1.76B | $1.44B | |
| EV / Sales | 4.71x | 6.89x | 8.13x | 6.61x | 5.69x | |
| EV / Op. cash flow | -6.25x | -64.76x | -40.49x | -15.25x | -16.63x | |
| EV / Free cash flow | -6.19x | -60.34x | -27.95x | -9.42x | -15.84x | |
| EV / EBITDA | -2.59x | -9.75x | -9.49x | -6.73x | -7.73x | |
| Net debt / EBITDA | 0.13x | 0.58x | 0.62x | 1.08x | 1.80x | |
| Current ratio | 6.64x | 6.86x | 8.84x | 6.53x | 7.06x | |
| Income quality | 0.40x | 0.14x | 0.22x | 0.43x | 0.45x | |
| Graham net-net | $3 | $5 | $6 | $6 | $8 | |
| Tax burden | 100.2% | 100.3% | 100.3% | 100.3% | 100.4% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $601.4M | $772.4M | $802.1M | $752.8M | $910.3M | |
| Invested capital | $668.9M | $852.3M | $891.3M | $838.0M | $925.4M | |
| Return on assets | -57.6% | -28.1% | -26.9% | -24.4% | -16.4% | |
| Operating ROA | -52.9% | -31.4% | -29.7% | -25.6% | -16.6% | |
| Return on tangible assets | -57.7% | -28.2% | -27.0% | -24.4% | -16.4% | |
| Return on equity | -71.9% | -34.4% | -32.0% | -28.9% | -19.4% | |
| Return on invested capital | -68.2% | -36.1% | -33.9% | -30.0% | -19.1% | |
| Return on capital employed | -68.7% | -36.3% | -34.0% | -30.0% | -19.2% | |
| Earnings yield | -37.9% | -10.2% | -10.4% | -13.1% | -10.8% | |
| Free cash flow yield | -15.4% | -1.6% | -3.4% | -9.1% | -5.1% | |
| Capex / Op. cash flow | -1.0% | -7.3% | -44.9% | -61.8% | -5.0% | |
| Capex / Depreciation | 14.1% | 24.1% | 220.2% | 1174.7% | 82.7% | |
| Capex / Sales | 0.8% | 0.8% | 9.0% | 26.8% | 1.7% | |
| SG&A / Sales | 134.2% | 85.8% | 95.2% | 97.6% | 92.8% | |
| R&D / Sales | 91.5% | 58.2% | 64.8% | 79.0% | 59.6% | |
| Stock comp / Sales | 0.0% | 59.4% | 69.5% | 81.2% | 44.9% | |
| Intangibles / Total assets | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| Days sales outstanding | 147d | 129d | 153d | 184d | 116d | |
| Days payables outstanding | 12d | 36d | 31d | 104d | 311d | |
| Operating cycle | 147d | 129d | 153d | 184d | 25d | |
| Cash conversion cycle | 135d | 93d | 122d | 80d | -286d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2023-09-05 | Pete Sessions | Sale | $0 - $1,000 |
| 2023-09-05 | Pete Sessions | Sale (Full) | $314.30 |
| 2021-05-07 | Frederick Stephen Upton | Purchase | $15,001 - $50,000 |
| 2021-04-19 | Pete Sessions | Purchase | $1,001 - $15,000 |
| 2021-03-04 | Tom Malinowski | Purchase | $15,001 - $50,000 |
Recent news
- 2026-09-07 UNDP and NEC Sign Memorandum of Understanding on the Use of AI and Other Digital Technologies to Realize a Nature-Positive Society TOKYO, Sept 7, 2026 - (JCN Newswire) - The United Nations Development Programme (UNDP) and NEC Corporation (NEC) have signed a Memorandum of Understanding (MOU)
- 2026-09-07 Cognizant Invests in America''s AI-Era Workforce Cognizant Invests in America''s AI-Era Workforce PR Newswire TEANECK, N.J., Sept. 7, 2026
- 2026-09-07 Hyosung Chairman Cho Hyun-Joon targets U.S. AI power market with 22.9kV SST Hyosung Chairman Cho Hyun-Joon targets U.S. AI power market with 22.9kV SST PR Newswire SEOUL, South Korea, Sept.
- 2026-09-04 ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer AstraZeneca''s ETCAMAHÂ (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been appro
- 2026-09-03 C3.ai: Early Turnaround Signals Are Here (Upgrade) C3.ai is upgraded to Buy, citing early signs of recovery under founder Thomas Siebel''s renewed leadership. Q1 bookings surged over 70% sequentially, reflecting successful sales team restructuring and renewed customer momentum. AI''s holistic enterprise AI stack and $650M cash position provide strategic flexibility and operational runway.
- 2026-09-03 Keysight Collaborates with the Centre for Assuring Autonomy at the University of York to Advance AI Safety Assurance for Software-Defined Vehicles [url="]Keysight Technologies, Inc.[/url] (NYSE: KEYS) and the [url="]Centre for Assuring Autonomy (CfAA)[/url] at the University of York (UK) announced a resear
- 2026-09-03 C3.ai: A Turnaround On Borrowed Time C3.ai, Inc. is undergoing a turnaround led by returning CEO Thomas Siebel, focusing on execution and restructuring sales strategies. Q1 2027 showed progress: bookings up 73% QoQ, federal bookings up 138% YoY, and positive free cash flow of $2.1 million. Non-GAAP gross margin improved to 50% and operating expenses fell sharply after a 40% headcount reduction, but revenue remains down YoY.
- 2026-09-03 C3.Ai Stock In Focus: Reports Q1 Double Beat — Then Guides Below Estimates C3.Ai Inc. (NYSE:AI) is trending Thursday after the company reported first-quarter results Wednesday after market close.
- 2026-09-02 C3.ai, Inc. (AI) Q1 2027 Earnings Call Transcript C3.ai, Inc. (AI) Q1 2027 Earnings Call Transcript
- 2026-09-02 C3.ai, Inc. (AI) Reports Q1 Loss, Beats Revenue Estimates C3.ai, Inc. (AI) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.37 per share a year ago.